An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replicationin vitro

Han Jin; Zhao Yan-ling; Shan Li-mei; Huang Feng-jiao; Xiao Xiao-he

doi:10.1007/BF02835751

Your Location：

Home >

Browse articles >

An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replicationin vitro

Updated：2021-08-27

- An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replicationin vitro
- Chinese Journal of Integrative Medicine Vol. 11, Issue 1, Pages: 54-56(2005)
- Affiliations：
  
  1. Department of Pharmacy, Hospital of PLA,Beijing,302
  2. Department of Pharmacy, Hubei Traditional Chinese Medical College,Wuhan
- Author bio：
- Funds：
  
  Supported by the Project of Military Science during the 9th Five-Year Plan Period (No. 01G19) and the National Natural Science Foundation (No. 39970911)
- DOI：10.1007/BF02835751
  CLC：
- Published：2005，
Scan for full text
Jin, H., Yan-ling, Z., Li-mei, S. et al. An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replicationin vitro, ., Chin. J. Integr. Med. 11, 54–56 (2005). https://doi.org/10.1007/BF02835751

Han Jin, Zhao Yan-ling, Shan Li-mei, et al. An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replicationin vitro. [J]. Chinese Journal of Integrative Medicine 11(1):54-56(2005)
Jin, H., Yan-ling, Z., Li-mei, S. et al. An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replicationin vitro, ., Chin. J. Integr. Med. 11, 54–56 (2005). https://doi.org/10.1007/BF02835751 DOI：

Han Jin, Zhao Yan-ling, Shan Li-mei, et al. An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replicationin vitro. [J]. Chinese Journal of Integrative Medicine 11(1):54-56(2005) DOI： 10.1007/BF02835751.

摘要

Objective: To explore the activities of Composite Artemisia Capillaris Tablet (CACT) against hepatitis B virus replicationin vitro.Methods: By means of radioimmunoassay (RIA)

Dot blot and Southern blot

the surface and e antigen production of 2.2.15 cells

HBV DNA in 2.2.15 cell culture medium and that in 2.2.15 cells were examined respectively.Results: HBsAg

HBeAg values of 2.2.15 cells treated by CACT were lower than those of the control

the HBV DNA quantities in culture medium and in 2.2. 15 cells decreased as compared with those cells with no treatment by CACT given to them.Conclusion: CACT could inhibit HBV DNA replication

showing its potential antiviral activity in hepatitis B treatment.

Abstract

Objective: To explore the activities of Composite Artemisia Capillaris Tablet (CACT) against hepatitis B virus replicationin vitro.Methods: By means of radioimmunoassay (RIA)

Dot blot and Southern blot

the surface and e antigen production of 2.2.15 cells

HBV DNA in 2.2.15 cell culture medium and that in 2.2.15 cells were examined respectively.Results: HBsAg

HBeAg values of 2.2.15 cells treated by CACT were lower than those of the control

the HBV DNA quantities in culture medium and in 2.2. 15 cells decreased as compared with those cells with no treatment by CACT given to them.Conclusion: CACT could inhibit HBV DNA replication

showing its potential antiviral activity in hepatitis B treatment.

关键词

Composite Artemisia Capillaris Tablet2.2.15 cellssurface antigene antigenHBV DNA

Keywords

Composite Artemisia Capillaris Tablet2.2.15 cellssurface antigene antigenHBV DNA

references

Korba BE, Milman. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res 1991);15: 217–228.

Zhao YL, Yuan HL, Xiao XH, et al. Experimental study of the inhibitory effect of Gantai capsule on HBsAg and HBeAg expression. Chin J Integr Med 2002;8(1): 56–58.

Korba BE, Boyd MR. Penciclovir is a selective inhibitor of hepatitis B virus in cultured human hepatoblastoma cells. Antimicrob Agents Chemother 1996; 40: 1282–1284.

David E, Zembower, Yuh-Meei Lin, et al. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiviral Res 1998;39: 81–88.

Belen’kii MS, Schinazi RF. Multiple drug effect analysis with confident interval. Antiviral Res 1994;25: 1–11.

FULL TEXT LINK

More>

Views

386

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰